SCHEMBL8949690

SCHEMBL8949690

CP(=O)(O)P(=O)(O)O.NCCCO

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 4/20 0.52
GABBR1 Q9UBS5 4/20 0.52
CYP1A2 P05177 2/20 0.52
TSHR P16473 1/20 0.52
THPO P40225 1/20 0.52
BLM P54132 3/20 0.50
LMNA P02545 2/20 0.50
CYP3A4 P08684 1/20 0.44
NFKB1 P19838 1/20 0.44
PMP22 Q01453 1/20 0.44
GABRR1 P24046 1/20 0.41
FDPS P14324 3/20 0.38
PDE3A Q14432 1/20 0.38
DRD3 P35462 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7799786 0.93 GABBR2 (0.50) GABBR2GABBR1CYP1A2TSHRTHPO
SCHEMBL8949817 0.91 GABBR2 (0.48) GABBR2GABBR1CYP1A2TSHRTHPO
SCHEMBL8949921 0.91 GABBR2 (0.48) GABBR2GABBR1CYP1A2TSHRTHPO
Phosphoric Acid SCHEMBL27481355 0.84 BLM (0.52) GABBR2GABBR1CYP1A2TSHRTHPO
Phosphoric Acid SCHEMBL6535607 0.84 BLM (0.52) GABBR2GABBR1CYP1A2TSHRTHPO
Butylamine SCHEMBL8949981 0.80 GABBR2 (0.58) GABBR2GABBR1CYP1A2TSHRTHPO
SCHEMBL8950061 0.78 GABBR2 (0.56) GABBR2GABBR1CYP1A2TSHRTHPO
SCHEMBL8949882 0.76 DNM1 (0.59) GABBR2GABBR1TSHRGABRR1FDPS
Propylamine SCHEMBL8950040 0.76 GABBR2 (0.46) GABBR2GABBR1CYP1A2TSHRTHPO
Phosphoric Acid SCHEMBL27508186 0.76 LMNA (0.50) GABBR2GABBR1CYP1A2TSHRTHPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5574024-A Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism EBETINO FRANK H (US) 1996-11-12 US disclosed
EP-0298553-B1 METHYLENE PHOSPHONOALKYLPHOSPHINATES, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM Norwich Eaton Pharmaceuticals, Inc. (US) 1992-01-15 EP disclosed